心臓除細動器販売市場- 世界の産業規模、動向、機会、予測、製品別、エンドユーザー別、地域別、競合別、2019年～2029年

世界の心臓除細動器販売市場は、2023年に99億2,000万米ドルと評価され、2029年までの予測期間のCAGRは5.25%で着実な成長が予測されています。

世界の心臓除細動器販売市場は、広範なヘルスケア産業の中でも重要なセグメントであり、生命を脅かす心臓不整脈への対応において極めて重要な役割を果たしています。除細動器は年々大きく進化し、救急医療現場、病院、救急車において不可欠な機器となっています。心臓除細動器販販売市場は、心血管疾患に対する意識の高まり、技術の進歩、世界の高齢化率の上昇を背景に力強い成長を遂げています。除細動器は、突然の心停止やその他の生命を脅かす不整脈の際に、心臓に電気ショックを与え、正常な心臓のリズムを回復させるように設計された医療機器です。

座りがちなライフスタイル、食生活の乱れ、高齢化などが原因で、心血管疾患の有病率は世界的に高まっています。このため、予防と緊急介入の両方に不可欠な心臓除細動器に対する需要が大幅に増加しています。心臓病学除細動器分野における継続的な技術進歩は、その有効性と安全性を高めています。スマート技術の統合、バッテリ寿命の向上、ユーザーフレンドリーなインターフェースなどは、市場の成長に貢献している技術革新の一部です。世界の政府やヘルスケア機関は、緊急対応システムを改善することの重要性を認識しつつあります。公共アクセス除細動（PAD）プログラムへの投資や、CPR（心肺蘇生法）に対する認識を高める取り組みが、市場の成長を後押ししています。

主な市場促進要因

心血管疾患の発生率の上昇が世界の心臓除細動器販売市場を牽引

意識向上とトレーニングへの取り組みの高まりが世界の心臓除細動器販売市場を牽引

主な市場課題

デバイスの高コスト

主要市場動向

技術の進歩

セグメント別洞察

製品別洞察

エンドユーザー別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の心臓除細動器販売市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別（植込み型除細動器（ICD）、体外式除細動器、装着型除細動器（WCDS）、高度救命救急装置、その他）
  • エンドユーザー別（病院・クリニック、外来診療センター、その他）
  • 地域別
  • 企業別（2022年）
• 市場マップ
  • 製品別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の心臓除細動器販売市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の心臓除細動器販売市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の心臓除細動器販売市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の心臓除細動器販売市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの心臓除細動器販売市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の心臓除細動器販売市場SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• ST. Jude Medical, Inc.
• Heartsine Technologies, Inc.
• Zoll Medical Corporation
• Medical Research Laboratories, Inc.
• Sorin Group
• Boston Scientific Corporation
• Physio-Control, Inc.
• Laerdal Medical Corporation
• Cardiac Science Corporation
• Medtronic Physio-Control Corporation
• Koninklijke Philips N.V.,
• Nihon Kohden Corporation
• Cardiac Science, Inc.
• Stryker Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Cardiology Defibrillators Devices Sales Market was valued at USD 9.92 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global cardiology defibrillators devices sales market is a critical segment within the broader healthcare industry, playing a pivotal role in addressing life-threatening cardiac arrhythmias. Defibrillators have evolved significantly over the years, becoming indispensable devices in emergency medical settings, hospitals, and ambulances. The cardiology defibrillators devices sales market is witnessing robust growth driven by increasing awareness of cardiovascular diseases, advancements in technology, and a rising aging population globally. Defibrillators are medical devices designed to deliver an electric shock to the heart, restoring normal heart rhythm during sudden cardiac arrest or other life-threatening arrhythmias.

The prevalence of cardiovascular diseases is escalating worldwide, attributed to sedentary lifestyles, poor dietary habits, and an aging population. This has significantly increased the demand for cardiology defibrillators devices, as they are essential for both prevention and emergency interventions. Ongoing technological advancements in the field of cardiology defibrillators devices are enhancing their efficacy and safety. Integration of smart technologies, improved battery life, and user-friendly interfaces are some of the innovations contributing to the market's growth. Governments and healthcare organizations globally are increasingly recognizing the importance of improving emergency response systems. Investments in public access defibrillation (PAD) programs and initiatives to raise awareness about CPR (Cardiopulmonary Resuscitation) are propelling market growth.

Key Market Drivers

Rising Incidence of Cardiovascular Diseases is Driving the Global Cardiology Defibrillators Devices Sales Market

Cardiovascular diseases (CVDs) remain a significant global health challenge, contributing to a substantial number of deaths worldwide. As the prevalence of CVDs continues to rise, the demand for advanced medical devices, such as cardiology defibrillators, has increased exponentially. This surge in demand is a direct response to the urgent need for effective interventions to address the rising incidence of heart-related ailments. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and sudden cardiac arrest. The World Health Organization (WHO) identifies CVDs as the leading cause of death globally, accounting for an estimated 17.9 million deaths annually. Unhealthy lifestyle choices, such as poor diet, lack of physical activity, and smoking, alongside increasing age and genetic predisposition, contribute to the growing burden of CVDs.

The global rise in life expectancy and aging populations is a significant driver behind the increasing prevalence of cardiovascular diseases. With age, individuals are more susceptible to developing conditions such as hypertension, atherosclerosis, and heart failure. Additionally, lifestyle factors, including sedentary behaviour, unhealthy diets, and stress, contribute to the escalating incidence of heart-related ailments. Urbanization and industrialization have brought about profound changes in people's lifestyles, contributing to the global epidemic of cardiovascular diseases. Urban environments often promote unhealthy habits such as a lack of physical activity, higher stress levels, and the consumption of processed foods. These factors, coupled with increased exposure to environmental pollutants, create a conducive environment for the development of cardiovascular diseases.

Cardiology defibrillators play a crucial role in the management of cardiovascular diseases, particularly in cases of sudden cardiac arrest (SCA). Sudden cardiac arrest occurs when the heart suddenly stops beating, leading to a cessation of blood flow to vital organs. Prompt intervention with a defibrillator, which delivers an electric shock to the heart, can restore a normal heartbeat and improve the chances of survival. As awareness of the life-saving potential of defibrillators grows, there has been a significant uptick in their adoption in various healthcare settings, including hospitals, clinics, and public spaces. Automated External Defibrillators (AEDs) are increasingly becoming more accessible in public places, providing individuals with the means to respond quickly to cardiac emergencies before professional medical assistance arrives. The escalating demand for cardiology defibrillators has fueled significant growth in the global market. Technological advancements have played a crucial role in the development of more sophisticated and user-friendly defibrillator devices. Integration of artificial intelligence, portable designs, and enhanced connectivity features are some of the key innovations that have enhanced the effectiveness and accessibility of these life-saving devices. Moreover, an increasing focus on public awareness campaigns and training initiatives for CPR (Cardiopulmonary Resuscitation) and AED use has contributed to a more informed and responsive general population. Governments and healthcare organizations are recognizing the importance of creating heart-safe environments by strategically placing AEDs in public spaces and ensuring that individuals are trained to use them effectively.

Growing Awareness and Training Initiatives is Driving the Global Cardiology Defibrillators Devices Sales Market

The field of cardiology has witnessed remarkable advancements in recent years, and one of the critical areas that has seen substantial growth is the market for cardiology defibrillator devices. These life-saving devices play a pivotal role in the management of cardiac arrhythmias and sudden cardiac arrest, making them indispensable in the realm of emergency cardiac care. The global cardiology defibrillators devices sales market is currently experiencing an upsurge, primarily attributed to the growing awareness about cardiovascular health and the implementation of extensive training initiatives worldwide. Public awareness campaigns and educational initiatives have played a crucial role in disseminating information about the importance of early defibrillation. Government health agencies, non-profit organizations, and healthcare providers are actively engaged in raising awareness about the signs of cardiac arrest, the need for immediate action, and the availability of automated external defibrillators (AEDs) in public spaces. This heightened awareness has not only increased the demand for AEDs but has also driven sales in the broader cardiology defibrillators devices market.

Alongside awareness campaigns, the emphasis on training initiatives has become pivotal in ensuring that individuals are equipped to respond effectively in emergency situations. Training programs in cardiopulmonary resuscitation (CPR) and AED usage have been implemented globally, empowering both healthcare professionals and the general public to administer life-saving interventions. This proactive approach has not only saved lives but has also contributed to the surge in demand for defibrillator devices.

Key Market Challenges

High Cost of Devices

While the demand for defibrillators continues to grow, the high cost of these devices presents a formidable obstacle. The complex engineering, sophisticated technology, and stringent regulatory requirements contribute to the elevated production costs, which are then transferred to the end-users. Hospitals, clinics, and emergency response units often find it challenging to allocate substantial budgets for acquiring defibrillators, limiting their ability to deploy these devices on a large scale. The high cost of defibrillators directly affects their accessibility in both developed and developing regions. In low-income countries, where healthcare budgets are already strained, the prohibitive prices of these devices create a stark disparity in access to life-saving interventions. Even in wealthier nations, budget constraints within healthcare systems can limit the widespread deployment of defibrillators, potentially impacting patient outcomes during cardiac emergencies.

Efforts are underway to address the high cost challenge and make defibrillators more accessible globally. Collaborations between industry stakeholders, governments, and non-profit organizations are crucial for developing strategies to reduce production costs without compromising on the quality and effectiveness of these devices. Research and development initiatives that focus on creating more cost-efficient technologies and manufacturing processes are essential for driving down overall prices. Government intervention through policies and incentives can play a pivotal role in promoting affordability and accessibility. Subsidies, tax breaks, and grants for healthcare institutions looking to invest in defibrillators can encourage widespread adoption. Governments can also collaborate with manufacturers to explore innovative financing models, such as lease programs or bulk purchasing agreements, to make defibrillators more economically viable for healthcare providers.

Key Market Trends

Technological Advancements

The field of cardiology is witnessing a revolutionary transformation propelled by rapid technological advancements, particularly in the domain of defibrillator devices. Defibrillators play a pivotal role in the management of cardiac arrhythmias and sudden cardiac arrest, and the market for these life-saving devices is experiencing unprecedented growth. Recent years have seen a significant integration of AI and ML technologies in the healthcare sector, and cardiology is no exception. Defibrillator devices are becoming smarter with the incorporation of advanced algorithms that can analyze patient data in real-time. AI-powered defibrillators can provide more accurate diagnostics, personalized treatment plans, and even predict potential cardiac events, enhancing the overall efficacy of the devices.

Technological advancements have led to the miniaturization of defibrillator devices, making them more portable and convenient for patients. Wearable defibrillators, in particular, have gained prominence, allowing individuals at risk of sudden cardiac arrest to carry a compact device that continuously monitors their heart rhythm. This trend not only promotes patient compliance but also ensures immediate intervention in case of any abnormalities. The integration of telemedicine and remote monitoring capabilities in defibrillator devices is another driving force in the market. Patients can now be remotely monitored by healthcare professionals, providing real-time data on their cardiac health. This facilitates early detection of issues, timely interventions, and reduces the need for frequent hospital visits. The global COVID-19 pandemic has further accelerated the adoption of remote monitoring solutions. Electrode technologies have undergone significant improvements, contributing to the enhanced performance of defibrillator devices. Novel electrode materials and designs ensure better contact with the patient's skin, leading to improved signal quality and accuracy. This results in more precise delivery of therapeutic shocks and reduces the risk of unnecessary interventions.

Modern defibrillator devices are increasingly equipped with enhanced data connectivity and interoperability features. Seamless integration with electronic health records (EHRs) and other healthcare systems allows for efficient data sharing and communication between different healthcare providers. This interconnected ecosystem fosters collaborative care, ensuring that patients receive the most comprehensive and coordinated treatment. Advances in genomics and molecular biology have paved the way for personalized medicine in cardiology. Defibrillator devices can now be tailored to an individual's genetic makeup, allowing for more targeted and effective treatments. This personalized approach improves patient outcomes and reduces the likelihood of adverse reactions to therapies.

Segmental Insights

Product Insights

Based on the category of Product, Implantable Cardioverter Defibrillator (ICDs) emerged as the dominant player in the global market for Cardiology Defibrillators Devices Sales in 2023. ICDs are sophisticated electronic devices designed to monitor and regulate abnormal heart rhythms, specifically ventricular tachycardia and ventricular fibrillation. These conditions can lead to sudden cardiac arrest, a medical emergency with potentially fatal consequences. ICDs are implanted subcutaneously or intravenously and continuously monitor the heart's rhythm, delivering electrical shocks when necessary to restore a normal heartbeat.

ICDs are highly effective in managing life-threatening arrhythmias. By continuously monitoring the heart's electrical activity, these devices can promptly detect abnormal rhythms and deliver therapeutic shocks to restore normalcy. This capability has proven to be crucial in preventing sudden cardiac death in high-risk patients. Continuous research and development in the field of cardiology have led to significant technological advancements in ICDs. Modern devices are equipped with sophisticated algorithms, remote monitoring capabilities, and programmable settings, enhancing their overall efficacy. These advancements have increased the acceptance and adoption of ICDs among healthcare professionals and patients alike. The global prevalence of cardiovascular diseases, including arrhythmias, has been on the rise. Factors such as sedentary lifestyles, poor dietary habits, and an aging population contribute to the increasing burden of cardiac conditions. As a result, there is a growing need for effective and reliable devices like ICDs to manage and mitigate the risks associated with these diseases.

End User Insights

The Hospitals & Clinics segment is projected to experience rapid growth during the forecast period. Hospitals and clinics boast well-established infrastructures, equipped with state-of-the-art facilities and skilled medical professionals. The presence of specialized cardiology units and emergency departments in these healthcare settings enhances their ability to diagnose and treat cardiovascular conditions promptly. This makes hospitals and clinics the natural epicenter for the utilization of cardiology defibrillators devices, as they can provide timely and effective interventions. With a growing emphasis on public awareness and training in basic life support (BLS) and advanced cardiac life support (ACLS), more individuals are becoming familiar with the importance of defibrillation in saving lives during cardiac emergencies. Hospitals and clinics, being primary hubs for medical education and training, contribute significantly to the dissemination of knowledge regarding the proper use of defibrillators. This heightened awareness further fuels the demand for these life-saving devices.

Regional Insights

North America emerged as the dominant player in the global Cardiology Defibrillators Devices Sales market in 2023, holding the largest market share in terms of value. North America has been at the forefront of technological innovation in the field of healthcare, and cardiology is no exception. Continuous investment in research and development has led to the creation of cutting-edge defibrillator devices that are more effective, efficient, and user-friendly. Advanced technologies such as implantable cardioverter-defibrillators (ICDs), wearable defibrillators, and automated external defibrillators (AEDs) have become standard components of cardiac care, contributing significantly to the region's dominant market position. The prevalence of cardiovascular diseases (CVDs) in North America is a key driver of the demand for cardiology defibrillators. Lifestyle factors, genetic predisposition, and an aging population contribute to the high incidence of conditions such as sudden cardiac arrest (SCA) and ventricular fibrillation. As a result, there is a growing need for defibrillation devices to effectively manage and respond to cardiac emergencies.

Key Market Players

ST. Jude Medical, Inc.

Heartsine Technologies, Inc.

Zoll Medical Corporation

Medical Research Laboratories, Inc.

Sorin Group

Boston Scientific Corporation

Physio-Control, Inc.

Laerdal Medical Corporation

Cardiac Science Corporation

Medtronic Physio-Control Corporation

Koninklijke Philips N.V.,

Nihon Kohden Corporation

Cardiac Science, Inc.

Stryker Corporation

Report Scope:

In this report, the Global Cardiology Defibrillators Devices Sales Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiology Defibrillators Devices Sales Market, By Product:

Implantable Cardioverter Defibrillator (ICDs) External Defibrillator Wearable Cardioverter Defibrillator (WCDS) Advanced Life Support Units Others

Cardiology Defibrillators Devices Sales Market, By End User:

Hospitals & Clinics Ambulatory Care Centers Others

Cardiology Defibrillators Devices Sales Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Cardiology Defibrillators Devices Sales Market.

Available Customizations:

Global Cardiology Defibrillators Devices Sales market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Cardiology Defibrillators Devices Sales Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Implantable Cardioverter Defibrillator (ICDs), External Defibrillator, Wearable Cardioverter Defibrillator (WCDS), Advanced Life Support Units, Others)
  • 4.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By End User
  • 4.3.3. By Region

5. Asia Pacific Cardiology Defibrillators Devices Sales Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By End User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By End User
  • 5.3.2. India Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By End User
  • 5.3.3. Australia Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By End User
  • 5.3.4. Japan Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By End User
  • 5.3.5. South Korea Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By End User

6. Europe Cardiology Defibrillators Devices Sales Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Germany Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Spain Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User
  • 6.3.4. Italy Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By End User
  • 6.3.5. United Kingdom Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By End User

7. North America Cardiology Defibrillators Devices Sales Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User

8. South America Cardiology Defibrillators Devices Sales Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. Argentina Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Colombia Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User

9. Middle East and Africa Cardiology Defibrillators Devices Sales Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. Saudi Arabia Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. UAE Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Cardiology Defibrillators Devices Sales Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. ST. Jude Medical, Inc.
  • 14.1.1. Company Snapshot
  • 14.1.2. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Heartsine Technologies, Inc.
• 14.3. Zoll Medical Corporation
• 14.4. Medical Research Laboratories, Inc.
• 14.5. Sorin Group
• 14.6. Boston Scientific Corporation
• 14.7. Physio-Control, Inc.
• 14.8. Laerdal Medical Corporation
• 14.9. Cardiac Science Corporation
• 14.10.Medtronic Physio-Control Corporation
• 14.11.Koninklijke Philips N.V.,
• 14.12.Nihon Kohden Corporation
• 14.13.Cardiac Science, Inc.
• 14.14.Stryker Corporation

15. Strategic Recommendations

16. About Us & Disclaimer